- Home
- Stories
Browsing Category
Stories
Adagene and Merck to Advance ADG106, an Anti-CD137 Agonist, in Combination with Pembrolizumab - OncoZine
Thu, Aug 19, 2021 20:27 ET
Google Ad’s New Conversion Value Rules: What They Are & How to Use Them - Search Engine Journal
Thu, Aug 19, 2021 17:51 ET
Virginia Tech experts weigh in on Afghanistan's takeover and migration - WDBJ7
Thu, Aug 19, 2021 17:26 ET